Gilead Sciences : GILD

All Gilead Sciences Articles

730 Articles

247sam | Dec 12, 2012 at 10:54 AM EST

Today’s Market Winners and Losers

The stock market is mixed Wednesday, with the Dow Jones Industrial Average up 0.06%, the Nasdaq down 0.03% and the…

Jon C. Ogg | Dec 5, 2012 at 4:28 PM EST

Stocks to Buy: Fortune’s 10 Picks for 2013 (ALGN, PNR, GILD, MCO, PAY, USB, F, CMCSA, UL, FMS)

Fortune is out with its top 10 stock picks for 2013. The list was divulged on CNBC late on Wednesday…

Jon C. Ogg | Dec 5, 2012 at 1:07 PM EST

The 10 Best S&P 500 Stocks of 2012 (PHM, S, WHR, EXPE, LEN, MPC, GILD, BAC, TSO, STZ)

The list of the best stocks of 2012 on the S&P 500 Index is one which makes sense in some…

247sam | Nov 12, 2012 at 11:12 AM EST

Today’s Market Winners and Losers

The stock market is down Monday, with the Dow Jones Industrial Average down 0.08%, the Nasdaq down 0.02% and the…

Jon C. Ogg | Nov 12, 2012 at 9:03 AM EST

Gilead Sciences and Celgene Score Major Drug Wins

ThinkstockWhen biotech stocks become as big as some of the second-tier drug stocks, it represents billions of dollars worth of…

Trey Thoelcke | Nov 12, 2012 at 8:04 AM EST

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

ThinkstockWe have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Trey Thoelcke | Oct 25, 2012 at 7:41 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

We have tracked the key short interest changes in the following biotech and emerging pharma companies: Alexion Pharmaceuticals Inc. (NASDAQ:…

Trey Thoelcke | Oct 11, 2012 at 8:25 AM EDT

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is mixed, judging by the short interest changes between the September 14 and September…

Trey Thoelcke | Sep 26, 2012 at 8:53 AM EDT

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

With a couple of exceptions, the short interest in biotech stocks is on the rise again, judging by the short…

Jon C. Ogg | Sep 17, 2012 at 3:16 PM EDT

BofA Adds GE, Gilead, Regions and Valero to Most Attractive Buy List

Key research changes have been made in the last few days over at Bank of America/Merrill Lynch’s research coverage. The…

Trey Thoelcke | Sep 13, 2012 at 8:52 AM EDT

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

The short interest in biotech stocks is generally falling, judging by the short interest changes from August 31 settlement date…

Douglas A. McIntyre | Aug 28, 2012 at 6:32 AM EDT

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Apple Inc. (NASDAQ: AAPL) pushes for a ban on eight Samsung phones. (Reuters) Best Buy Co. Inc. (NYSE: BBY) will…

Trey Thoelcke | Aug 27, 2012 at 8:10 AM EDT

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

The short interest in biotech stocks is generally rising, judging by the short interest changes from August 15 settlement date…

Trey Thoelcke | Aug 10, 2012 at 9:51 AM EDT

Biotech: Dendreon and Regeneron Draw Short Interest

The short interest data is out from the July 31 settlement date and, with a couple of notable exceptions, short…

Jon C. Ogg | Aug 7, 2012 at 8:39 AM EDT

Top Analyst Upgrades and Downgrades (AMGN, AMT, AMAT, COH, DELL, FLEX, GILD, HPQ, KCG, LEAP, NTAP, SANM, SPLK, VE, VRTX, VVUS, WMT)

Jon OggThese are some of the top analyst upgrades, downgrades and initiations seen from Wall St. research calls this Tuesday…

1 … 41 42 43 44 45 … 49

Gilead Sciences : GILD

All Gilead Sciences Articles

Today’s Market Winners and Losers

Stocks to Buy: Fortune’s 10 Picks for 2013 (ALGN, PNR, GILD, MCO, PAY, USB, F, CMCSA, UL, FMS)

The 10 Best S&P 500 Stocks of 2012 (PHM, S, WHR, EXPE, LEN, MPC, GILD, BAC, TSO, STZ)

Today’s Market Winners and Losers

Gilead Sciences and Celgene Score Major Drug Wins

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

BofA Adds GE, Gilead, Regions and Valero to Most Attractive Buy List

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

Biotech: Dendreon and Regeneron Draw Short Interest

Top Analyst Upgrades and Downgrades (AMGN, AMT, AMAT, COH, DELL, FLEX, GILD, HPQ, KCG, LEAP, NTAP, SANM, SPLK, VE, VRTX, VVUS, WMT)

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Gilead Sciences : GILD

All Gilead Sciences Articles

Today’s Market Winners and Losers

Stocks to Buy: Fortune’s 10 Picks for 2013 (ALGN, PNR, GILD, MCO, PAY, USB, F, CMCSA, UL, FMS)

The 10 Best S&P 500 Stocks of 2012 (PHM, S, WHR, EXPE, LEN, MPC, GILD, BAC, TSO, STZ)

Today’s Market Winners and Losers

Gilead Sciences and Celgene Score Major Drug Wins

Short Interest in Biotech Remains Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech Is Mixed (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Short Interest in Biotech on the Rise (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

BofA Adds GE, Gilead, Regions and Valero to Most Attractive Buy List

Short Interest in Biotech Wanes (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS, IBB)

Media Digest (8/28/2012) Reuters, WSJ, NYT, Bloomberg

Biotech: Vertex and VIVUS Draw Short Interest (ALXN, AMGN, ARNA, BIIB, CELG, DNDN, GILD, ILMN, ONXX, PCYC, REGN, VRTX, VVUS)

Biotech: Dendreon and Regeneron Draw Short Interest

Top Analyst Upgrades and Downgrades (AMGN, AMT, AMAT, COH, DELL, FLEX, GILD, HPQ, KCG, LEAP, NTAP, SANM, SPLK, VE, VRTX, VVUS, WMT)

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do